HAI and Snakebite Programme Partner, James Ashe Antivenom Trust, Applaud Government Action on Antivenom at Bio-Ken Snakebite Symposium

by SABRINA HENNECKE, Assistant Programme Officer (Snakebite)

Take away the snakes and the sunburn, and Watamu, Kenya truly does look like paradise. Endless white sand cozies up to a sparkling blue ocean, surrounded by lush greenery and sprinkled with towering coconut palms. Nothing could be more different from my drafty home in cold,

HAI’s Research into Access to Sexual and Reproductive Health Commodities Now in Full Swing

by BOBBI KLETTKE, Communications Manager

The methodology has been finalised. The pilot testing is complete. And data collection officials are trained.

Health Action International’s study into the price, availability and affordability of more than 30 sexual and reproductive health (SRH) commodities is now rolling out across all three of our study countries—Uganda,

Insulin Still Unattainable for Many Living with Diabetes Worldwide: ACCISS Study Review in The Lancet D&E


An ACCISS Study Review of the global insulin market, called ‘Constraints and Challenges in Access to Insulin: A Global Perspective, was published Friday in The Lancet Diabetes & Endocrinology. Co-authored by ACCISS Study leaders, David Beran, Marg Ewen and Richard Laing, the Review describes why insulin is still unattainable for approximately half of all people who need it.

World Health Assembly Executive Board 136: YP-CDN, NWIA and HAI intervention on the WHO’s internship programme

4 February 2015 | by TIM REED
At the 136th World Health Organization (WHO) Executive Board meeting in Geneva this past week, we had the privilege of developing an intervention with the Young Professionals Chronic Disease Network (YP-CDN) and the Network of WHO Intern Alumni (NWIA) regarding the WHO’s internships programme.

World Health Assembly Executive Board 136: YP-CDN and HAI intervention on the progress achieved in the prevention and control of non-communicable diseases

by KAVITHA KOLAPPA (Young Professionals Chronic Disease Network) and TIM REED (HAI)

Thank you Chair and esteemed delegates:
I am speaking on behalf of Health Action International and the Young Professionals Chronic Disease Network.
At last year’s Executive Board meeting, we heard an impassioned plea from South Africa whose draft reforms to their domestic intellectual property policy were under threat by a lobbying firm who planned a subversive campaign to block these reforms,

HAI Launches Innovative Global Study to Improve Access to Insulin

by MARG EWEN, Global Pricing Co-ordinator and ACCISS Study Co-investigator

The global need for insulin, a hormone that converts sugar, starches and other food into needed energy for everyday activities, is immense. An estimated 100 million people with diabetes need it. This includes all with type 1 diabetes, plus 20 to 30 per cent of people with type 2 diabetes.

New materials help assess medicines policies and interventions


Many countries, no matter their geographic region or level of economic development, have tremendous opportunity to improve medicines prices, availability and affordability for their citizens. To aid in this endeavour, various medicines policies and interventions exist. It can be difficult, however, for countries to determine which policies and interventions to implement;